End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
45.61 CNY | +2.96% | +9.43% | +0.84% |
Apr. 26 | Hengrui Pharma Gets Nod to Trial Insulin Aspart Injection; Shares Up 3% | MT |
Apr. 17 | Jiangsu Hengrui Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Jiangsu Hengrui Medicine Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Jiangsu Hengrui Medicine Co., Ltd.
Nomura |
EPS Revisions
- Stock Market
- Equities
- 600276 Stock
- Consensus Jiangsu Hengrui Medicine Co., Ltd.